If you are already on metformin and interested in more effective weight loss, PlexusDx providers can evaluate whether adding semaglutide injection or another GLP-1 therapy aligns with your health goals and medical history
The weight-loss results at 48-weeks found with the 12 mg retatrutide group an average weight reduction of 24.2% was achieved, while the placebo group only saw a 2.1% change
Is there a licensed prescriber available for questions between scheduled visits
Low levels of B12 can lead to tiredness, weakness, poor concentration, and mood changes
Biomarkers of selenium status
Finally, beyond their role in controlling metabolic processes, GLP-1 receptor agonists also show promising potential benefits in treating cardiovascular and neurodegenerative diseases